Phillip Hoopes, MD
Ophthalmology · Draper, UTNPI 1992794846
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,906 of the $26,179 with a category attached, or 95.1%. Rxsight Inc accounts for 96.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $23,138 and has fallen 99.3% since, to $157 in 2025. Among ophthalmology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $844.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$25K
- Carl Zeiss Meditec, Inc.$311
- Alcon$306
- Glaukos Corporation$237
- Johnson & Johnson Surgical Vision, Inc.$103
- Carl Zeiss Meditec USA, Inc.$54
- plus $46 from 3 others
Across 10 payments — averaging $8692.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$80K
- Bausch & Lomb Americas Inc.$7K
What the payments were for
- Consulting fees$24,90695%
- Food & beverage$1,2385%
- Gifts$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 5 | $25,121 |
| Carl Zeiss Meditec, Inc. | 4 | $311 |
| Alcon | 9 | $306 |
| Glaukos Corporation | 5 | $237 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $103 |
| Carl Zeiss Meditec USA, Inc. | 2 | $54 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Dompe US, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,179 in reported general payments places this provider in the 95th percentile of 191 ophthalmology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 232 | $7,654 |
| MoxifloxacinMoxifloxacin Hcl | 177 | $5,420 |
| Ketorolac Tromethamine | 205 | $4,775 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 34 | $2,849 |
| Latanoprost | 93 | $807 |
| Ofloxacin | 47 | $519 |
| Timolol Maleate | 26 | $209 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Draper
- Austin BohnerDraper$3K
- Iqbal AhmedSalt Lake City$895K
- Robert CionniSalt Lake City$161K
- Ron LordSt. George$61K
- Zachary ZavodniSalt Lake City$51K
- Majid MoshirfarSalt Lake City$44K
- Marc Steffen Schmitz-ValckenbergSalt Lake City$43K
- Rachel SimpsonSalt Lake City$39K
- Austin NakatsukaSalt Lake City$27K
- Sharon RichensSt George$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.